Candel Therapeutics, Inc. (CADL)

Candel Therapeutics, Inc. (CADL) is a healthcare company (biotechnology) based in the United States. The share price is $5.40, down 7.06% on the day, which values the company at $423.61M. Price as of 18 Nov 2026, 12:25 UTC, from Yahoo Finance.

Key facts

Share price
$5.40−7.06% today
Market value
$423.61M
200-week average
$5.184% above
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

Candel Therapeutics, Inc. in more detail

CADL trades at -3.8× next year's expected earnings. It sits 4% above its 200-week average of $5.18.

In its favour: More cash than debt. Worth checking: Weak Piotroski score; Share count keeps rising.

Candel Therapeutics, Inc. (CADL): questions and answers

What is Candel Therapeutics, Inc.'s market cap?

Candel Therapeutics, Inc. is valued at $423.61M at a share price of $5.40.

Is CADL above its 200-week moving average?

Yes. CADL is 4.2% above its 200-week average of $5.18. Long-term investors watch that line because strong companies rarely trade below it for long.

Does CADL pay a dividend?

Candel Therapeutics, Inc. does not currently pay a regular dividend.

Cite this page

Funkfolio, “Candel Therapeutics, Inc. (CADL) stock: price, valuation and fundamentals”, data as of 18 November 2026. https://funkfolio.com/stock/CADL

Underlying data: Yahoo Finance; company filings with the SEC.